Cargando…

Protein Arginine N-methyltransferases 5 and 7 Promote HIV-1 Production

Current therapies for human immunodeficiency virus type 1 (HIV-1) do not completely eliminate viral reservoirs in cells, such as macrophages. The HIV-1 accessory protein viral protein R (Vpr) promotes virus production in macrophages, and the maintenance of Vpr is essential for HIV-1 replication in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Hironobu, Suzuki, Takehiro, Tsuchiya, Kiyoto, Gatanaga, Hiroyuki, Taura, Manabu, Kudo, Eriko, Okada, Seiji, Takei, Masami, Kuroda, Kazumichi, Yamamoto, Tatsuo, Hagiwara, Kyoji, Dohmae, Naoshi, Aida, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150949/
https://www.ncbi.nlm.nih.gov/pubmed/32210193
http://dx.doi.org/10.3390/v12030355
Descripción
Sumario:Current therapies for human immunodeficiency virus type 1 (HIV-1) do not completely eliminate viral reservoirs in cells, such as macrophages. The HIV-1 accessory protein viral protein R (Vpr) promotes virus production in macrophages, and the maintenance of Vpr is essential for HIV-1 replication in these reservoir cells. We identified two novel Vpr-binding proteins, i.e., protein arginine N-methyltransferases (PRMTs) 5 and 7, using human monocyte-derived macrophages (MDMs). Both proteins found to be important for prevention of Vpr degradation by the proteasome; in the context of PRMT5 and PRMT7 knockdowns, degradation of Vpr could be prevented using a proteasome inhibitor. In MDMs infected with a wild-type strain, knockdown of PRMT5/PRMT7 and low expression of PRMT5 resulted in inefficient virus production like Vpr-deficient strain infections. Thus, our findings suggest that PRMT5 and PRMT7 support HIV-1 replication via maintenance of Vpr protein stability.